The Human Right to Health and HIV/AIDS: South Africa and South-South Cooperation to Reframe Global Intellectual Property Principles and Promote Access to Essential Medicines

George, Erika

doi:10.2979/indjglolegstu.18.1.167

Cited by 13 publications

(7 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Els Torrelee notes that, in her meeting with access to medicines activists in Africa, there was a shared view that IPR is currently not the main barrier to access to medicines in Africa, but that this may become a more significant issue in years to come (A2M, 2011). Human rights activism in this field commenced in response to the issue of access to anti-retroviral medicines in South Africa (George, 2011). It is the success of this movement that civil society is today trying to replicate it in other therapeutic areas.…”

Section: Resultsmentioning

confidence: 99%

The New Political Economy of Pharmaceuticals

2013

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

The New Political Economy of Pharmaceuticals

2013

View full text Add to dashboard Cite

“…Other authors argued that political instability, underdevelopment, widespread poverty and poor infrastructure are the major reasons for the rapid spread of HIV in African countries [5].…”

Section: Introductionmentioning

confidence: 99%

Morbidity and mortality in the antiretroviral era in sub-Saharan Africa: a systematic review protocol

Ghislain

Mushebenge

Magula

2020

Preprint

View full text Add to dashboard Cite

Background Worldwide, Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV/AIDS) remains a public health problem. The prevalence of HIV in Sub-Saharan Africa is one of the uppermost in the world. Method/design Observational studies will be systematically reviewed reporting on morbidity and mortality in the antiretroviral therapy (ART) era in Sub-Saharan Africa. We will search relevant studies from the following databases: PubMed, Medline, CINAHL. Two review authors will independently screen titles abstracts and full text articles in duplicate, extract data and assess the bias. Discrepancies will be resolved by discussion or arbitration of a third review author. The study will use the Preferred Reporting Item of Systematic Review (PRISMA 2015) guideline. Discussion This review will summarise the determinants of morbidity and causes of mortality in the antiretroviral era in Sub-Saharan Africa. The findings of this study will help to improve opportunistic infection’s prevention and clinical outcomes in ART era. Systematic review registration PROSPERO CDR42019141933

show abstract

“…Among them, concurrent or simultaneous sexual intercourse practices by African men is argued as a major role player in the vast spread of HIV in Sub-Saharan African countries as opposed to high-income countries where there are serial monogamy practices [4]. Other authors argued that political instability, underdevelopment, widespread poverty and poor infrastructure are the major reasons for the rapid spread of HIV in African countries [5]. Sub-Saharan Africa has the biggest share of the 40 million people currently living with HIV and AIDS in the world [6].…”

Section: Introductionmentioning

confidence: 99%

Morbidity and Mortality in the Antiretroviral Era in Sub-saharan Africa: A Systematic Review Protocol

Ghislain

Mushebenge

Magula

2020

Preprint

View full text Add to dashboard Cite

Background: Worldwide, Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome (HIV/AIDS) remains a public health concern. The prevalence of HIV in Sub-Saharan Africa is one of the uppermost in the world. This study aims to identify the determinants of morbidity and specific causes of mortality in the antiretroviral treatment (ART) era in Sub-Saharan Africa.Method/design: Observational studies will be systematically reviewed reporting on morbidity and mortality in the antiretroviral therapy (ART) era in Sub-Saharan Africa. We will search for relevant studies from Google Scholar, PubMed, and CINAHL databases. Two review authors will independently screen titles, abstracts and full-text articles in duplicate, extract data and assess the bias. Discrepancies will be resolved by discussion or arbitration of a third review author. The study will use the Preferred Reporting Item of Systematic Review (PRISMA 2015) guideline. We will use R software to analyze and synthesize the data, the information will be captured into a spreadsheet regarding the most causes of hospitalization and death related to HIV in the antiretroviral treatment, Graphic displays will be used to visually compare the prevalence of comorbidities across the study region. This will also enable to provide any form of patterns in the comorbidities.Discussion: This review will summarize the determinants of morbidity and causes of mortality in the antiretroviral era in Sub-Saharan Africa. The findings of this study will help to improve opportunistic infection’s prevention and clinical outcomes in the ART era.Systematic review registration: PROSPERO CDR42019141933

show abstract

The Human Right to Health and HIV/AIDS: South Africa and South-South Cooperation to Reframe Global Intellectual Property Principles and Promote Access to Essential Medicines

Abstract: The HIV/AIDS pandemic has had a devastating and disproportionate impact in countries of the Global South.

Cited by 13 publications

References 29 publications

The New Political Economy of Pharmaceuticals

The New Political Economy of Pharmaceuticals

Morbidity and mortality in the antiretroviral era in sub-Saharan Africa: a systematic review protocol

Morbidity and Mortality in the Antiretroviral Era in Sub-saharan Africa: A Systematic Review Protocol

Contact Info

Product

Resources

About